Galderma:
Delivered against full year guidance for another consecutive year with strong financial performance
· Galderma achieved net sales of 4.082 B USD, up 8.5% year-on-year on a constant currency basis[1] in FY 2023, at the higher end of its 6-9% net sales growth 2023 FY guidance, and surpassed 4 B USD in net sales for the first time
– Positive momentum across all product categories outperforming fast growing market segments, with year-on-year net sales growth on a constant currency …